ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)

SEC filing

ARCUTIS BIOTHERAPEUTICS, INC.

ARQT · CIK 1787306

4 · Aug 24, 2026 · Curran Terrie sold 1,072 shares at $26.04/share ($27,912); exercised options for 1,072 shares

Curran Terrie sold 1,072 shares at $26.04/share ($27,912); exercised options for 1,072 shares

FORM 4

xslF345X06/wk-form4_1787602781.xmlSEC.gov

Graphics and non-inline formats (not embedded below).